跳转至内容
Merck
所有图片(1)

Key Documents

BP1210

利托那韦

British Pharmacopoeia (BP) Reference Standard

别名:

1,3-噻唑-5-基甲基 N-[(2S,3S,5S)-3-羟基-5-[[(2S)-3-甲基-2-[[甲基-[(2-丙-2-基-1,3-噻唑-4-基)甲基]氨基甲酰基]氨基]丁酰基]氨基]-1,6-二苯基己基-2-基]氨基甲酸酯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C37H48N6O5S2
分子量:
720.94
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

品質等級

agency

BP

API 家族

ritonavir

形狀

solid

儲存期限

limited shelf life, expiry date on the label

包裝

pkg of 100 mg

製造商/商標名

BP

儲存條件

dry at room temperature

顏色

off-white

mp

122-126  °C

溶解度

ethanol: soluble
isopropanol: soluble
methanol: soluble

密度

1.239 g/cm3 at 20 °C

應用

pharmaceutical
pharmaceutical small molecule

格式

neat

運輸包裝

ambient

儲存溫度

2-8°C

InChI

1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1

InChI 密鑰

NCDNCNXCDXHOMX-XGKFQTDJSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Ritonavir BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Ritonavir Oral Solution
  • Ritonavir Tablets
  • 包裝

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    其他說明

    Sales restrictions may apply.

    象形圖

    Exclamation mark

    訊號詞

    Warning

    危險聲明

    危險分類

    Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

    儲存類別代碼

    11 - Combustible Solids

    水污染物質分類(WGK)

    WGK 3

    閃點(°F)

    Not applicable

    閃點(°C)

    Not applicable


    从最新的版本中选择一种:

    分析证书(COA)

    Lot/Batch Number

    抱歉,我们目前尚未线上提供该产品的COA。

    如需帮助,请联系 客户支持

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    RP-HPLC method development and validation for simultaneous estimation of Lopinavir and Ritonavir in tablet dosage form
    Bindu MJ, et al.
    International Journal of Science and Engineering Applications, 5(1), 77-77 (2017)
    HPTLC method for simultaneous determination of lopinavir and ritonavir in capsule dosage form
    Sulebhavikar VA, et al.
    Journal of Chemistry, 5(4), 706-712 (2008)

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系技术服务部门